SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Tag: CATT

    Summary of Research and Developments in Macular Degeneration, 2010-2011

    Posted on June 1, 2011 by droberts
  • June 1, 2011

    Summary of Research and Developments in Macular Degeneration, 2010-2011

    by Dan Roberts June 19, 2011 Introduction Since 2006, I have done my best to condense the high points of the previous year’s macular degeneration research into a single report that is concise and understandable for the layperson. I do so, because I understand first hand how important it is to be aware of everything […]

      Also posted in
    • Research and Developments
  • Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

    Posted on April 22, 2011 by droberts
  • April 22, 2011

    Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

    The CATT Research Group April 2011 In 2005, clinical trials established the efficacy of ranibizumab (Lucentis, Genentech) for the treatment of neovascular age-related macular degeneration (AMD), the leading cause of legal blindness in the United States. While awaiting approval for ranibizumab from the Food and Drug Administration, ophthalmologists began treating neovascular AMD with off-label use […]

      Also posted in
    • Research and Developments
  • Summary of Research and Developments in Macular Degeneration: 2007-2008

    Posted on June 1, 2008 by droberts
  • June 1, 2008

    Summary of Research and Developments in Macular Degeneration: 2007-2008

    Compiled and edited by Dan Roberts JUNE 2007 Omega-3 Proving to be Beneficial on Several Fronts Recent studies have shown that Omega-3 fatty acids and fish consumption may reduce the risks of age-related macular degeneration (AMD), Alzheimer’s disease, inflammation and depression. The Age-Related Eye Disease Study (AREDS) Research Group showed that dietary total Omega-3 and […]

      Also posted in
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.